Synthesize Bio
PrivateLast Round
Seed
Sep 17, 2025
Total Funding Raised
$10M
Company Overview
Synthesize Bio operates in Healthcare & Life Sciences and is based in Seattle, Washington. Its latest recorded funding round was a Seed round in September 2025.
Synthesize Bio is a biotechnology company that develops a generative genomics platform using multi-modal deep learning models to simulate biological processes and accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Foundation
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synthesize Bio Comparables
Compare Synthesize Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chan Zuckerberg Biohub | 89% | |
| Chai Discovery | 83% | |
| Cassidy Bio | 81% |
For institutional investors. Book with your work email.
Synthesize Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synthesize Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| AI2 Incubator | Seed |
| Madrona Venture Group | Seed |
| Point Field Partners | Seed |
| Sahsen Ventures | Seed |
| Inner Loop Capital | Seed |
| AI House | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 27, 2026
Grew 24% QoQ from 17 to 21 employees.
For institutional investors. Book with your work email.
Synthesize Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synthesize Bio's valuation, stock price, and market status.
Is Synthesize Bio a public or private company?
Synthesize Bio is a private company.
What is the current stock price of Synthesize Bio?
Synthesize Bio is a private company, so its shares have no public market price. Caplight tracks Synthesize Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synthesize Bio worth (valuation)?
Valuation information for Synthesize Bio is not publicly available.
Can I buy Synthesize Bio stock?
Synthesize Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synthesize Bio's last funding round?
Synthesize Bio's most recent funding round was Seed on September 17, 2025.
Who are the main investors in Synthesize Bio?
Key investors in Synthesize Bio include Madrona Venture Group.
Will Synthesize Bio IPO soon?
No public IPO plans have been announced for Synthesize Bio.
How can I track Synthesize Bio secondary market activity?
Caplight tracks bids, offers, and trades in Synthesize Bio's shares on secondary markets.